Bayforest Capital’s Eli Lilly LLY Stock Holding History

Bayforest Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Buy	100 +13	+15%	+$13.3K	0.11%	366
2026 Q1	$80K	Buy	+87	New	+$88.2K	0.09%	429

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bayforest Capital's LLY Position: Q2 2026 in Review

Bayforest Capital increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $13.3K and bringing the position to 100 shares worth $120K. The position accounts for 0.11% of the portfolio, ranked #366.

Bayforest Capital first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Bayforest Capital held 100 shares of Eli Lilly worth $120K as of Q2 2026.
Bayforest Capital bought 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
Eli Lilly made up 0.11% of Bayforest Capital's portfolio in Q2 2026, its #366 holding.
Bayforest Capital first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.